Product Description
Since last many years Saintroy Lifescience is leading manufacture, export and supplier of Thiotepa for Injection from Surat, Gujarat, India. Thiotepa for Injection use in combination with other chemotherapy agents to treat cancer.
Tags: Thiotepa for Injection manufacturer, Thiotepa for Injection Exporter, Thiotepa for Injection supplier, and Thiotepa for Injection, whogmp approved Thiotepa for Injection manufacturer and supplier, Thiotepa for Injection distributor,Thiotepa for Injection shipper, Thiotepa for Injection 100 mg Thiotepa for Injection 100 mg supplier, Thiotepa for Injection 100 mg .
ISO/GMP/cGMP/WHOGMP/NAFDAC approved, PPB Kenya approved/USFDA approved/EUGMP approved/MOH Iran approved manufacturing facility in Gujarat, India.
Registration: Saintroy Lifescience is interested in registration of own brand or customer brands in ministry of health of clients country and we also provide the products samples, COA, COPP, ACTD or CTD dossier, DMF, Manufacturing license, Free sales certificate and other required documents.
Versatile and Effective Cancer TreatmentThiotepa for Injection is especially valued for its broad application in oncology, targeting ovarian, breast, bladder cancers, and malignant effusions. It offers healthcare professionals flexibility in administration routes, which can be tailored to the patient's clinical situation for optimal results.
Safe Handling and Storage RecommendationsGiven its cytotoxic potential, Thiotepa must be handled with care using protective gear. It is supplied in a glass vial meeting USP standards and should be stored in cool, dry conditions. Dispose of any unused reconstituted solution promptly to maintain a safe clinical environment.
Premium Quality and ComplianceManufactured to USP standards and designed for hospital use, this product guarantees quality and safety. The lyophilized powder ensures stability, and its clear reconstitution protocol supports ease of preparation for medical professionals.
FAQ's of Thiotepa for Injection:
Q: How should Thiotepa for Injection be reconstituted and administered?
A: Thiotepa must be reconstituted with sterile water for injection prior to use. Administration can be intravenous, intramuscular, intravesical, or intraperitoneal according to the prescribed protocol. Only trained healthcare professionals in hospital settings should prepare and deliver this medication.
Q: What conditions is Thiotepa for Injection prescribed to treat?
A: Thiotepa is indicated for the treatment of ovarian, breast, and bladder cancers, in addition to malignant effusions. Its versatility in cancer care makes it an important agent for multiple oncological indications.
Q: When should unused reconstituted Thiotepa solution be discarded?
A: Any unused thawed or remaining Thiotepa solution should be discarded immediately after use, as per hospital protocols and cytotoxic waste disposal guidelines. This helps prevent accidental exposure and maintains safety standards.
Q: Where should Thiotepa for Injection vials be stored for optimal stability?
A: The glass vials should be stored in a cool and dry place, away from direct light and extreme temperatures, in compliance with the manufacturer's recommendations and hospital procedures.
Q: What protective measures are necessary when handling Thiotepa for Injection?
A: Because Thiotepa is a cytotoxic drug, healthcare staff must handle it with appropriate personal protective equipment, such as gloves, gowns, and protective eyewear to minimize the risk of exposure.
Q: What are the benefits of this product's lyophilized powder formulation?
A: The lyophilized powder format enhances the product's shelf life, allowing stable storage for up to two years, and offers ease of reconstitution by healthcare professionals for timely administration.